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AND WOLFGANG MULLER-RUCHHOLTZ 
Because successful human islet transplantation 
requires large quantities of viable islets that must be 
separated from the highly immunogenic exocrine 
tissue and because handpicking is too time-consuming 
and laborious to be clinically relevant, a new approach 
for solving this problem has been established in rat 
models. It is based on the principle that magnetic 
microspheres (MMSs) coupled to lectins with binding 
specificity for the exocrine tissue portion are trapped 
in an electromagnetic field, thus providing effluent 
islets of a high degree of purity. In this study our aim 
was to adapt this princip'le to human islet preparations. 
In this context our prime interest was focused on a 
lectin suitable for human pancreatic tissue. Of 19 
different lectins tested, only 1, Wisteria floribunda 
agglutinin (WFA), is suitable, as shown by 
immunofluorescence, MMS-Iectin binding, and 
magnetic separation. Diabetes 38 (Suppl. 1):146-49, 
1989 
Because hand picking of islets, a commonly used purification procedure in rodents, is impracticable for human material due to the large quantities of clean islets needed, there is a great demand for 
a more efficient approach to this problem (1). We previously 
reported on a very effective and simple purification proce-
dure for collagenase-digested rat islets, based on magnetic 
microspheres (MMSs) coupled to a lectin with selective bind-
ing specificity for exocrine tissue (2). Our aim in this study 
was to adapt this technique to human islet material. Ulex 
europaeus agglutinin I (UEA-I), the lectin used for rat exo-
crine tissue, proved to be unsuitable for human tissue, be-
cause it also binds to endocrine cells. Thus, studies with 
crude-human islet preparations were focused on the anal-
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ysis of 18 other lectins in indirect immunofluorescence and 
binding studies with MMS-coupled lectins. 
MATERIALS AND METHODS 
Human islet preparation. Crude-human islet preparations 
were obtained from cadaveric pancreases according to the 
technique of Gray et al. (3) and stored in liquid nitrogen until 
further use. Of 18 preparations, only isolation 7 (consisting 
mainly of underdigested islets) and isolation 15 (consisting 
mainly of well-digested islets) were used for magnetic sep-
aration. 
Lectins. The following lectins (agglutinins) were used: An-
guilla anguilla (AAA), Bauhinia purpurea (BPA), Canavalia 
ensiformis (ConA), Oolichos biflorus (OBA), Erythrina cris-
tagalli (ECA), Griffonia simplicifolia I (GSA-I), Griffonia sim-
plicifolia II (GSA-II), Helix pomatia (HPA), Lens culinaris 
(LCA), Limulus polyphemus (LPA), Mac/ura pomifera (MPA), 
Arachis hypogaea (PNA), Ricinus communis I (RCA-I), Gly-
cine max (SBA), succinyl Canavalia ensiformis (Succ. ConA), 
succinyl Triticum vulgaris (Succ. WGA), Ulex europaeus I 
(UEA-I), Triticum vulgaris (WGA), and Wisteria floribunda 
(WFA). Lectins were purchased from Medac (Hamburg, 
FRG) 
Preparation of MMS and lectin coupling. The MMSs were 
prepared by modification of the basic procedure described 
elsewhere (4,5). Briefly, 75 mg bovine serum albumin (BSA) 
and 23 mg Fe30 4 were dissolved in 250 j-ll distilled water, 
mixed with 25 ml cottonseed oil, and sonicated in an ice-
water bath six times for 1 min each. The emulsion was im-
mediately squirted into 150 ml oil at 120°C. The heat-stabi-
lized MMSs were purified of oil by washing with acetone. 
Thereafter, they were activated with 2.5% glutaraldehyde, 
and after several washings, they were incubated with a lectin 
(20 j-lg lectin/mg MMS) in phosphate-buffered saline (PBS) 
for 2 h. Finally, they were washed with PBS and stored in 
PBS + 0.02% azide + 1 % BSA + 0.05% Tween at 4°C. 
Before use, MMSs were washed with sterile PBS/2% glucose 
several times and resuspended in RPMI-1640 medium with 
10% fetal calf serum (RPMI-FCS). 
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Fluorescence studies on isolated islets. Crude-islet prep-
arations were tested with 19 lectins for their binding speci-
ficity to exocrine tissue : 100 1-'-1 of crude-islet suspension was 
incubated with 100 1-'-1 fluorescein isothiocyanate (FITC)-Ia-
beled lectin (diluted 1:10 with PBS for 40 min at 4°C in the 
dark), and after three washings, it was prepared for micro-
scopic evaluation on glass slides. 
MMS binding studies on isolated islets. Lectin-coupled 
MMSs were bound to islets in the following manner: 200 1-'-1 
crude islet suspension was incubated with 20 1-'-1 (0.2 mg) 
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lectin-coupled MMS for 40 min on ice. MMS binding was 
evaluated microscopically. 
Magnetic separation procedure. Approximately 200-300 
crude islets were incubated with 2-3 mg lectin-coupled 
MMS in 5 ml RPMI-FCS for 40 min at 4°C in a 50-ml cu lture 
flask. Binding of these MMSs to exoc rine cel ls was tested 
microscopically . After addition of 5 ml RPMI-FCS, the fl ask 
was positioned in an electromagnetic fie ld of 800 G for 4 
min and 1500 G for 2 min. Thereafter, puri fied is lets were 
collected from the bottom of the flask, but exocrine tissue 
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FIG. 1. A: underdigested human islet stained with dithizone; islet appears as dark spot in tissue center. B: crude human islet preparation 
incubated with Wisteria floribunda-coupled lectin magnetic microspheres before magnetic separation. C: after magnetic separation exocrine cells 
were trapped in magnetic fraction. 0 : purified islets collected in eluate. x 550. 
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LARGE-SCALE PREPARATION OF ISLETS 
TABLE 1 
Binding pattern of lectins to human exocrine or endocrine 
pancreas portion 
Groups of lectins 
Binding 1 * 2t 3t 4§ 511 
Lectins coupled Exocrine +++ + + + 
to fluorescein 
isothiocyanate Endocrine + 
Lectins coupled Exocrine ++ 
to magnetic 
microspheres Endocrine + -/+ 
6~ 
+++ 
++ 
+ + +, Strong; + +, medium; + weak; -, no detectable bind. 
*Ulex europaeus. 
tAnguil/a anguil/a, 8auhinia purpurea, Oolichos biflorus, Griffonia 
simplicifolia I and 11, Helix pomatia, Limulus polyphemus, and Ar-
achis hypogaea (peanut agglutinin). 
tSuccinyl concanavalin A, succinyl Triticum vulgaris (wheat germ), 
and Glycine max (soybean) agglutinins and Ricinus communis I. 
§Erythrina cristagal/i, Lens culinaris, concanavalin A, and wheat 
germ agglutinin. 
IIMaciura pomifera. 
~Wisteria floribunda. 
bound to MMS-Iectin complexes and unbound complexes 
remained attached to the flask wall in the magnetic field. 
The separation procedure was repeated three times with the 
magnetic fraction. To distinguish islets from exocrine cells, 
separated islets were stained with dithizone (Sigma, Munich, 
FRG), which forms a red complex with the Zn2 + of the en-
docrine cells (Fig. 1 A). Thus, separated islets could be ana-
Iyzed microscopically for purification status. A test of the 
viability of the islets was performed with light microscopy 
with propidium iodide and fluorescein diacetate. 
RESULTS 
REACTIVITY PATTERN OF LECTINS 
Fluorescence studies. Each lectin was tested for binding 
with at least three islet preparations (Table 1). UEA-I, which 
had proven in earlier studies to be highly selective for rat 
exocrine tissue (2), also stained human endocrine tissue and 
was therefore unsuitable for purification of human islet prep-
arations. Eight of 19 lectins did not react with either exocrine 
or endocrine tissue, and 9 of 19 showed only weak reactivity 
with the exocrine tissue. Only 1 lectin, WFA, reacted strongly 
and selectively with the human exocrine tissue, i.e., not with 
the endocrine tissue. 
MMS binding studies. The potential of lectin binding to 
human exocrine tissue was codetermined by the coupling 
of the lectin to MMS (Table 1). Four lectins, which had def-
initely shown positive, although weak, staining of the exo-
crine tissue portion in the fluorescence studies, showed no 
binding to exocrine cells after coupling to MMS. Another 
lectin with weak selective reactivity in fluorescence, MPA, 
also showed no binding after coupling to MMS. Of all lectins 
tested, only WFA maintained its highly selective binding pat-
tern after coupling to MMS. Therefore, only WFA was used 
for further separation studies. 
PURITY, YIELD, AND VIABILITY OF 
WFA-MMS-SEPARATED HUMAN ISLETS 
Exemplary for the varying quality of collagenase digestion, 
two crude-islet preparations, 15 (most islets without exocrine 
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rim) and 7 (most islets with exocrine rim), were chosen for 
WFA-MMS separation in the electromagnetic field. With 
preparation 15 the purity of the eluate (islets) was ~90-95%, 
and the yield of islets was ~ 70% when the results of the 
separation were analyzed with the dithizone-staining tech-
nique. With preparation 7 the purity of the eluate was again 
~90-95%; however, the yield of islets was only ~20%. Typ-
ical results of a magnetic separation run with islet preparation 
15 are shown in Fig. 1, 8-0. Staining with propidium iodide 
and fluorescein diacetate revealed viability of islets (of both 
preparations) before and after magnetic separation of 
~90%. 
DISCUSSION 
There are at least two reasons for the failure of human islet 
grafts to function satisfactorily (6): the quantity of islets 
grafted is too small, and the graft is highly contaminated by 
exocrine tissue (3). According to very recent observations 
of ours, the exocrine debris within the crude islet preparation 
contains numerous HLA-OR+ cells-far more than the islets 
themselves-and thus may greatly determine graft immu-
nogenicity, as revealed by mixed Iymphocyte-islet cultures. 
Therefore, islet purification appears to be a requisite for suc-
cessful human transplantation. 
Handpicking of islets, well established in rodents, is far 
too time-consuming and laborious for human material; thus, 
new approaches to solve this problem are in great demand 
(3). The MMS technique, as developed in our laboratory (5), 
was first tested for rat islet purification (2). We showed that 
islet purity, yield, and function after magnetic separation 
were good to excellent. This was considered a model study 
that is transferable to the human situation. However, it be-
came obvious that the proper choice of a lectin of strong 
binding potential and high binding specificity to the exocrine 
tissue portion may be determined by the mammalian species 
in question. UEA-I, which had proved to be a good choice 
for binding to rat exocrine tissue, was useless for human 
tissue. Our results further showed that it may be misleading 
to screen for a lectin in fluorescence tests only. Of six lectins 
investigated, only one, WFA, maintained its high degree of 
binding potential for the exocrine tissue portion after cou-
pling to the MMS. It appears that binding of the lectin to the 
MMS may alter the binding of the lectin to its specific sugar 
receptor on the cell. 
Purity of the islet eluate was ~90-95% in both prepara-
tions, a figure that nearly reaches our earlier rat data (95-
98%; 2) and indicates the efficiency of our separation tech-
nique. However, as expected, the yield of islets in the eluate 
strongly decreased (from 70 to 20%) when an underdigested 
islet preparation was purposely separated. The 70% yield 
with a well-digested islet preparation is nearly identical to 
the yields obtained with rats (2). About 30% islets were found 
in the magnetic fraction for various reasons: 1) as a con-
sequence of underdigestion; 2) because of nonspecific trap-
ping among exocrine tissue debris; and 3) because of a still-
inadequate flow system, as indicated by the presence of 
well-digested islets (identified with dithizone) that had no 
MMS-Iectin complexes on their surfaces. Studies are in prog-
ress to improve the flow system and to improve the yield by 
a subsequent separation run of the recovered and resus-
pended magnetic field fraction. Furthermore, repetitive runs 
may be performed at a lower electromagnetic field strength, 
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allowing islets to pass that contain exocrine tissue rims as 
only minor components. Thereafter, N-acetyl-D-galactosa-
mine, the WFA-specific sugar, may be added to the resulting 
effluent fraction that would contain MMS to dissociate the 
MMS from cells. This approach has been shown to be non-
toxic for human islet cells in recent preliminary tests. In con-
clusion, we hope that the principle described here is fast, 
simple, safe, and effective enough to become helpful for 
solving the problem of large-scale purification of islets for 
transplantation in humans. 
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